Pfizer Inc



    Today's change

    0.18 / +0.52%

    1 year change


    As of May 27 2016 21:02 BST. Data delayed by at least 15 minutes.

Search for Pfizer Inc and
  1. May 24, 2016

    Tax inversion crackdown claims $8bn fertiliser deal

    A US government crackdown on tax inversions has prompted two fertiliser makers to scrap their $8bn deal because it...

  2. FT Alphaville

    May 20, 2016

    Friday RAW: are bidders circling Sobi again?

    Lately, M&A reporting has been going a bit gonzo. This week alone we’ve had a recruitment website claim that Occidental...

Special Reports

  1. FT Health: Vaccines

    In today’s connected world, where outbreaks of infectious disease can spread faster th...
  2. Corporate Longevity

    The FT launches a global investigation into the mixture of innovation and focus that c...
Search more Special Reports on this topic.

  1. May 16, 2016

    Freeport-McMoRan gains ground on broker upgrade

    Freeport-McMoRan was one of the leading gainers on the S&P 500 on Monday after analysts at Cowen & Co boosted their...

  2. May 16, 2016

    Pfizer buys Anacor for $5.2bn to boost innovation

    Pfizer has agreed to buy the Silicon Valley biotech group Anacor for $5.2bn, as it continues to build up the innovative...

  3. May 16, 2016

    Biotech groups sink their teeth into the Big Apple

    When Cellectis, a French biotech group, opened a US subsidiary last year, it dispensed with tradition and picked an...

  4. Fast FT

    May 16, 2016

    Pfizer snaps up Anacor for $5.2bn

    It’s no Allergan. But barely a month after it scrapped plans to acquire its rival, Pfizer has found a new acquisition...

  5. May 14, 2016

    Pfizer blocks its drugs from use in executions

    Pfizer has taken steps to ensure that none of its products are used in lethal injections, the largest US drugmaker said...

  6. May 11, 2016

    Staples tie-up with Office Depot halted by US regulators

    Staples and Office Depot became the latest victims of US regulators, as the two largest stationery retailers in America...

  7. Fast FT

    May 10, 2016

    US judge blocks Staples, Office Depot tie-up

    A federal judge ruled on Tuesday in favour of the US government’s request for an injunction to halt the merger between...

  8. May 10, 2016

    Norwegian Cruise Line shares fall on downbeat outlook

    Norwegian Cruise Line shares fell on Tuesday after the company issued a downbeat second-quarter earnings outlook,...

  9. May 10, 2016

    Allergan: kicking the habit

    Cold turkey is not always the best way to kick addiction. Sometimes an intermediate step is needed. For Allergan, the...

  10. Fast FT

    May 10, 2016

    Allergan plans $10bn share buyback

    Allergan, the maker of Botox, said it would buy back up to $10bn of its stock, sending shares in the company up by 5...

  11. May 9, 2016

    Pfizer to trial triple-combination cancer treatment

    Pfizer plans to test a combination of three novel cancer drugs in humans next year, as the US drugmaker seeks to make...

  12. May 8, 2016

    Allergan chief persists with his prescription for growth

    When Brent Saunders, chief executive of Allergan, agreed to sell the drugmaker to Pfizer for $160bn in November last...

  13. May 6, 2016

    Cellectis hails success in ridding British infant of cancer

    A second child with a previously incurable form of leukaemia has been successfully treated with an important new cell...

  14. May 3, 2016

    Pfizer weighs split to cut tax bill

    Pfizer is looking for new ways to cut its US tax bill including moving part of its business overseas following a...

  15. Fast FT

    May 3, 2016

    Pfizer hunts for new ways to cut tax bill

    Ian Read, chief executive of Pfizer, has suggested moving part of the drugmaker to a low-tax jurisdiction following a...

  16. Fast FT

    May 3, 2016

    Pfizer tops forecasts, lifts guidance

    Shares in Pfizer have jumped almost 3 per cent in pre-market trading after the US drugmaker reported first quarter...

  17. Fast FT

    May 3, 2016

    Markets: FX machinations lead to cautious mood

    Forex is in focus as the yen hits a fresh 18-month high, the dollar index slips to a 15-month low and the Aussie is...

  18. April 28, 2016

    What pawnbrokers can teach central banks

    Three decades ago, the club of triple A-rated American corporate borrowers was a busy place. About 60 big companies,...

  19. April 27, 2016

    Daniel Loeb warns of hedge fund ‘killing field’

    One of the most powerful US hedge fund managers believes that the industry is in “first innings of a washout” after a...

  20. April 25, 2016

    Drug prices: Tweaking the formula

    What is the value of a human life? It is one of the most fraught questions in public policy as governments around the...

  21. April 25, 2016

    Vaccine development needs global alliance

    Who has saved the most lives in human history? Claims can be made for various scientific pioneers and political...

  22. April 25, 2016

    Vaccines are among big pharma’s best-selling products

    Ask people to name Pfizer’s best-selling product and many would opt for one of its most famous drugs: Viagra, for...

  23. Fast FT

    April 19, 2016

    US M&A off to worst Q2 since 2009

    Not much for banks to cheer about. Following a string of lacklustre results from big banks, hopes for investment...

  24. April 11, 2016

    M&A crackdown puts bond investors on edge

    A crackdown on mergers and acquisitions has investors on edge over the potential that competition for corporate bonds...

  25. April 7, 2016

    US takes tougher stance on deals under Obama

    The Obama administration’s bid to scuttle the $25bn takeover of Baker Hughes by Halliburton is less a sudden turn...

  26. April 7, 2016

    M&A deals worth $370bn torpedoed by Obama administration

    US companies have abandoned $370bn of large deals since President Barack Obama came into power in 2009, after...

  27. April 7, 2016

    A real-world solution to the tax repatriation ruckus

    There are not many questions on which a man such as Tim Cook, chief executive officer of Apple , would agree with...

  28. April 6, 2016

    Collapse of $160bn Pfizer and Allergan merger shocks corporate US

    The collapse of Pfizer’s $160bn merger with Allergan on Wednesday brought the total value of abandoned deals this year...

  29. April 6, 2016

    Pfizer chief’s long quest for tax inversion ends in failure

    For more than two years, Ian Read, the plain-speaking Scottish chief executive of Pfizer, had been on a mission to find...

  30. April 6, 2016

    M&A failures: deep breaths

    What were they thinking? The largest US cable TV company tried to buy the second largest. The second and third-largest...

  31. Fast FT

    April 6, 2016

    2016 M&A withdrawals highest since '07

    The White House’s efforts to deter tax inversion deals saw Pfizer abandon its $160bn pursuit of botox maker Allergan on...

  32. April 6, 2016

    US Treasury shatters Pfizer chief Ian Read’s merger dreams

    Ian Read cannot be faulted for his persistence. For more than two years the chief executive of Pfizer has been...

  33. April 6, 2016

    Pfizer merger collapse is serious failure of management

    Anyone who cares about decent management, long-term corporate commitment and the reputation of business will take grim...

  34. April 6, 2016

    Pfizer: plan C

    The problem is growth, and has been ever since Lipitor, the biggest-selling drug in history, lost patent protection...

  35. Fast FT

    April 6, 2016

    Pfizer, Allergan formally end $160bn merger

    It’s officially over. The Viagra-meets-Botox merger is not meant to be. Pfizer and Allergan confirmed on Wednesday that...

  36. Fast FT

    April 6, 2016

    Pfizer to kill $160bn Allergan merger

    Pfizer has decided to kill its $160bn merger with Allergan, after the Obama administration took new steps to bring an...

  37. April 5, 2016

    US crackdown on inversions came ‘out of left field’

    For the past couple of years, President Barack Obama has been accused of failing to prevent US companies from...

  38. April 5, 2016

    Hedge funds knocked by Allergan’s fall

    Four of the US’s largest hedge funds saw as much as $900m knocked off the value of their holdings in Allergan when new...

Search for Pfizer Inc and